GSTM1 and depressive symptom measurement: Although only a few case studies on Hb deep brain stimulation have been published, they report beneficial outcomes in patients suffering from schizophrenia (81), depression (82, 83), obsessive-compulsive disorder (84), and bipolar disorder (85).